Lupin Ltd
NSE:LUPIN

Watchlist Manager
Lupin Ltd Logo
Lupin Ltd
NSE:LUPIN
Watchlist
Price: 2 169.45 INR 0.42%
Market Cap: 989.7B INR
Have any thoughts about
Lupin Ltd?
Write Note

Lupin Ltd
Investor Relations

In the bustling landscape of the global pharmaceutical industry, Lupin Ltd. stands as a testament to the transformative power of innovation and strategic foresight. Founded in 1968 by Dr. Desh Bandhu Gupta, Lupin embarked on its journey with a clear vision: to deliver high-quality drugs at affordable prices. Over the years, it has adeptly navigated the complex world of pharmaceuticals to become a formidable player in the generics market. Its success is built on a robust portfolio that includes a diverse range of generic and branded formulations across many therapeutic segments such as cardiovascular, diabetology, asthma management, and anti-tuberculosis. The company prioritizes intensive research and development, paving the way for both the introduction of new generics and the development of advanced drug delivery systems. Such focus ensures Lupin maintains a competitive edge in both established markets like the United States and emerging markets across Asia and Africa.

The company’s financial engine is powered largely by its extensive manufacturing and distribution capabilities, which are strategically positioned across the globe to maximize efficiency and meet demand. With state-of-the-art facilities in India supplemented by strategic acquisitions and partnerships overseas, Lupin produces a wide array of active pharmaceutical ingredients (APIs) and finished dosages, allowing it to capture value across different stages of the drug supply chain. This vertically integrated model not only enhances profit margins but also provides the agility to respond quickly to market shifts. Furthermore, Lupin's strategic emphasis on biosimilars and specialty drugs reinforces its commitment to innovation, unlocking new revenue streams amid growing global healthcare demands. As Lupin continues to expand its footprint, it remains anchored in its mission to improve healthcare outcomes, embodying a legacy where profitability harmoniously aligns with purpose.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Ms. Vinita D. Gupta
CEO & Executive Director
No Bio Available
Mr. Ramesh Swaminathan
Executive Director, Global CFO, CRO & Head of API Plus SBU
No Bio Available
Mr. Nilesh Deshbandhu Gupta
MD & Executive Director
No Bio Available
Mr. Christoph Funke
Chief Technical Operations Officer
No Bio Available
Mr. Sreeji Gopinathan
Chief Information Officer
No Bio Available
Dr. Shahin Fesharaki
President -Global Chief Scientific Officer
No Bio Available
Mr. Ravi Agrawal
Sr. Vice President of Investor Relations and M&A
No Bio Available
Dr. Sofia Mumtaz
President of Legal and Compliance of Australia, Japan & Canada Business
No Bio Available
Mr. Amit Kumar Gupta
Company Secretary & Compliance Officer
No Bio Available
Ms. Rajalakshmi Azariah
Vice President & Global Head of Corporate Communications
No Bio Available

Contacts

Address
MAHARASHTRA
Mumbai
Laxmi Towers, 'B' Wing,, Bandra Kurla Complex,, Bandra (East),
Contacts
+912266402222
www.lupin.com